A WDR35-dependent coat protein complex transports ciliary membrane cargo vesicles to cilia

  1. Tooba Quidwai
  2. Jiaolong Wang
  3. Emma A Hall
  4. Narcis A Petriman
  5. Weihua Leng
  6. Petra Kiesel
  7. Jonathan N Wells
  8. Laura C Murphy
  9. Margaret A Keighren
  10. Joseph A Marsh
  11. Esben Lorentzen
  12. Gaia Pigino
  13. Pleasantine Mill  Is a corresponding author
  1. MRC Institute of Genetics and Molecular Medicine, United Kingdom
  2. Aarhus University, Denmark
  3. MRC Human Genetics Unit, University of Edinburgh, United Kingdom
  4. Max-Planck Institute of Molecular Cell Biology and Genetics, Germany
  5. Max Planck Institute of Molecular Cell Biology and Genetics, Germany
  6. The University of Edinburgh, United Kingdom
  7. University of Edinburgh, United Kingdom
  8. Human Technopole, Italy

Abstract

Intraflagellar transport (IFT) is a highly conserved mechanism for motor-driven transport of cargo within cilia, but how this cargo is selectively transported to cilia is unclear. WDR35/IFT121 is a component of the IFT-A complex best known for its role in ciliary retrograde transport. In the absence of WDR35, small mutant cilia form but fail to enrich in diverse classes of ciliary membrane proteins. In Wdr35 mouse mutants, the non-core IFT-A components are degraded and core components accumulate at the ciliary base. We reveal deep sequence homology of WDR35 and other IFT-A subunits to α and ß' COPI coatomer subunits, and demonstrate an accumulation of 'coat-less' vesicles which fail to fuse with Wdr35 mutant cilia. We determine that recombinant non-core IFT-As can bind directly to lipids and provide the first in-situ evidence of a novel coat function for WDR35, likely with other IFT-A proteins, in delivering ciliary membrane cargo necessary for cilia elongation.

Data availability

Source Data (Figures 1B,C; 2B; 3B; as well as Figure 3 Supplement 1C, Figure 7 Supplement-1C) have been uploaded with the submission containing numerical data of all graphs shown in the figures and figure supplements. We have also uploaded the Excel or/and Prism files as source data in addition to the data points which have been referenced, as appropriate in the Figure legends. Source data of raw and full uncropped blots for Figures 3B, C, E and Figure 3 Supplement 1A, as well as Figure 5B, C and Figure 5 Supplement 1 B-D are uploaded as zipped files per figure. For Figure 7F, we have included the ROIs used for calculations uploaded in a single folder including all numerical data of Figure 7 (7B-D,F) graphs at Dryad https://doi.org/10.5061/dryad.m37pvmd33. All analysis tools have been made available on GitHub (https://github.com/IGMM-ImagingFacility/Quidwai2020 WDR35paper), as described in Materials and Methods. Proteomics data files are be uploaded ProteomeXchange (Identifer: PXD022652), with the accession number is available with the paper and is now publically available.Project Name: A WDR35-dependent coatomer transports ciliary membrane proteins from the Golgi to the ciliaProject accession: PXD022652

The following data sets were generated
    1. Mill P
    2. Quidwai T
    3. Murphy L
    4. Pigino G
    (2021) Figure 7- source data 1.
    Dryad Digital Repository, doi:10.5061/dryad.m37pvmd33.

Article and author information

Author details

  1. Tooba Quidwai

    Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5248-9010
  2. Jiaolong Wang

    Aarhus University, Aarhus, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  3. Emma A Hall

    MRC Human Genetics Unit, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Narcis A Petriman

    Aarhus University, Aarhus, Denmark
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3189-7530
  5. Weihua Leng

    Max-Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Petra Kiesel

    Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Jonathan N Wells

    Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3700-020X
  8. Laura C Murphy

    MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Margaret A Keighren

    MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Joseph A Marsh

    Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Esben Lorentzen

    Aarhus University, Aarhus, Denmark
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6493-7220
  12. Gaia Pigino

    Human Technopole, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  13. Pleasantine Mill

    MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom
    For correspondence
    Pleasantine.Mill@igmm.ed.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5218-134X

Funding

European Molecular Biology Laboratory (Short Term Fellowship)

  • Tooba Quidwai

European Commission (H2020,Grant Agreement number 888322)

  • Narcis A Petriman

Lister Institute of Preventive Medicine (Research Prize Fellow)

  • Joseph A Marsh

Novo Nordisk (Grant No. NNF15OC0014164)

  • Jiaolong Wang
  • Narcis A Petriman
  • Esben Lorentzen

Carlsbergfondet (Grant No. CF19-0253)

  • Jiaolong Wang
  • Narcis A Petriman
  • Esben Lorentzen

European Commission (H2020 Grant No. 819826)

  • Weihua Leng
  • Petra Kiesel
  • Gaia Pigino

European Commission (H2020 No. 866355)

  • Tooba Quidwai
  • Emma A Hall
  • Pleasantine Mill

Medical Research Council (Core unit funding No. MC_UU_12018/26)

  • Tooba Quidwai
  • Emma A Hall
  • Laura C Murphy
  • Margaret A Keighren
  • Pleasantine Mill

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Richard A Kahn

Ethics

Animal experimentation: We followed international, national and institutional guidelines for the care and use of animals. Animal experiments were carried out under UK Home Office Project Licenses PPL 60/4424, PB0DC8431 and P18921CDE in facilities at the University of Edinburgh (PEL 60/2605) and were approved by the University of Edinburgh animal welfare and ethical review body.

Version history

  1. Received: April 26, 2021
  2. Accepted: November 4, 2021
  3. Accepted Manuscript published: November 4, 2021 (version 1)
  4. Accepted Manuscript updated: November 12, 2021 (version 2)
  5. Version of Record published: January 11, 2022 (version 3)

Copyright

© 2021, Quidwai et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,462
    views
  • 514
    downloads
  • 30
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Tooba Quidwai
  2. Jiaolong Wang
  3. Emma A Hall
  4. Narcis A Petriman
  5. Weihua Leng
  6. Petra Kiesel
  7. Jonathan N Wells
  8. Laura C Murphy
  9. Margaret A Keighren
  10. Joseph A Marsh
  11. Esben Lorentzen
  12. Gaia Pigino
  13. Pleasantine Mill
(2021)
A WDR35-dependent coat protein complex transports ciliary membrane cargo vesicles to cilia
eLife 10:e69786.
https://doi.org/10.7554/eLife.69786

Share this article

https://doi.org/10.7554/eLife.69786

Further reading

    1. Cancer Biology
    2. Cell Biology
    Dongyue Jiao, Huiru Sun ... Kun Gao
    Research Article

    Enhanced protein synthesis is a crucial molecular mechanism that allows cancer cells to survive, proliferate, metastasize, and develop resistance to anti-cancer treatments, and often arises as a consequence of increased signaling flux channeled to mRNA-bearing eukaryotic initiation factor 4F (eIF4F). However, the post-translational regulation of eIF4A1, an ATP-dependent RNA helicase and subunit of the eIF4F complex, is still poorly understood. Here, we demonstrate that IBTK, a substrate-binding adaptor of the Cullin 3-RING ubiquitin ligase (CRL3) complex, interacts with eIF4A1. The non-degradative ubiquitination of eIF4A1 catalyzed by the CRL3IBTK complex promotes cap-dependent translational initiation, nascent protein synthesis, oncogene expression, and cervical tumor cell growth both in vivo and in vitro. Moreover, we show that mTORC1 and S6K1, two key regulators of protein synthesis, directly phosphorylate IBTK to augment eIF4A1 ubiquitination and sustained oncogenic translation. This link between the CRL3IBTK complex and the mTORC1/S6K1 signaling pathway, which is frequently dysregulated in cancer, represents a promising target for anti-cancer therapies.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Natalia Dolgova, Eva-Maria E Uhlemann ... Oleg Y Dmitriev
    Research Article Updated

    Mediator of ERBB2-driven cell motility 1 (MEMO1) is an evolutionary conserved protein implicated in many biological processes; however, its primary molecular function remains unknown. Importantly, MEMO1 is overexpressed in many types of cancer and was shown to modulate breast cancer metastasis through altered cell motility. To better understand the function of MEMO1 in cancer cells, we analyzed genetic interactions of MEMO1 using gene essentiality data from 1028 cancer cell lines and found multiple iron-related genes exhibiting genetic relationships with MEMO1. We experimentally confirmed several interactions between MEMO1 and iron-related proteins in living cells, most notably, transferrin receptor 2 (TFR2), mitoferrin-2 (SLC25A28), and the global iron response regulator IRP1 (ACO1). These interactions indicate that cells with high-MEMO1 expression levels are hypersensitive to the disruptions in iron distribution. Our data also indicate that MEMO1 is involved in ferroptosis and is linked to iron supply to mitochondria. We have found that purified MEMO1 binds iron with high affinity under redox conditions mimicking intracellular environment and solved MEMO1 structures in complex with iron and copper. Our work reveals that the iron coordination mode in MEMO1 is very similar to that of iron-containing extradiol dioxygenases, which also display a similar structural fold. We conclude that MEMO1 is an iron-binding protein that modulates iron homeostasis in cancer cells.